Ercolano et al. previously generated a COX-2 knockout in mouse B16F10 melanoma cells by the CRISPR/Cas9 technique and observed marked effects on invasiveness and motility in vitro and tumor growth in vivo [29]. The gene discussed is PTGS2; the disease is neoplasm.